skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
PAD Regimen (Code C114387)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: PAD Regimen

Definition: A chemotherapy regimen containing bortezomib, doxorubicin and dexamethasone regimen used in the treatment of multiple myeloma.

Label: PAD Regimen

NCI Thesaurus Code: C114387 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL472264  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Bortezomib/Doxorubicin/Dexamethasone Regimen
PAD Regimen
PS-341/Adriamycin/Dexamethasone Regimen
Velcade/Adriamycin/Dexamethasone Regimen

External Source Codes: 
PDQ Closed Trial Search ID 759138
PDQ Open Trial Search ID 759138 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C114387
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom